PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis.
Panigrahy D; Singer S; Shen LQ; Butterfield CE; Freedman DA; Chen EJ; Moses MA; Kilroy S; Duensing S; Fletcher C; Fletcher JA; Hlatky L; Hahnfeldt P; Folkman J; Kaipainen A; The Journal Of Clinical Investigation, 2002, vol. 110, issue 7, p 923, ISSN 00219738. ISBN 00219738.
Full Text Resources Located for this Citation